SEC FORM 4/A

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

HENSON MICHAEL R

(Last)

(First)

(Middle)

821 FOX LANE

(Street)

SAN JOSE

95131

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
MICRUS ENDOVASCULAR CORP [ MEND ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/21/2005

4. If Amendment, Date of Original Filed (Month/Day/Year)
06/23/2005

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	06/21/2005		C		958⁽¹⁾	A	⁽²⁾	75,135	D
Common Stock	06/21/2005		C		6,387⁽¹⁾⁽³⁾	A	⁽²⁾	81,522	D
Common Stock	06/21/2005		C		95,978⁽⁴⁾	A	⁽²⁾	109,726	I	JAIC-Henson MedFocus Fund, LLC
Common Stock	06/21/2005		C		27,777⁽⁵⁾	A	⁽²⁾	34,089	I	JAIC-Henson MedFocus Fund II, LLC

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Series D Preferred Stock	⁽²⁾	06/21/2005		C			958	⁽²⁾	⁽⁶⁾	Common Stock	958	$0.00	0	D
Series D Preferred Stock	⁽²⁾	06/21/2005		C			6,387	⁽²⁾	⁽⁶⁾	Common Stock	6,387	$0.00	0	D
Series E Preferred Stock	⁽²⁾	06/21/2005		C			27,777⁽⁷⁾	⁽²⁾	⁽⁶⁾	Common Stock	27,777	$0.00	0	I	JAIC-Henson MedFocus Fund, LLC
Series E Preferred Stock	⁽²⁾	06/21/2005		C			27,777	⁽²⁾	⁽⁶⁾	Common Stock	27,777	$0.00	0	I	JAIC-Henson MedFocus Fund II, LLC

Explanation of Responses:

1. Converted Series D Preferred Stock erroneously omitted from the original Form 4 from a Series D warrant that had been exercised in April 2005.

2. Converts on a 1 to 1 basis.

3. On the original Form 4, the form of ownership of these 6,387 shares was erroneously reflected being indirectly held by the Henson Family Trust, however the shares are directly held by Michael R. Henson.

4. The original Form 4 reflected the amount of 123,755, however, 27,777 of these shares of Common Stock (converted from Series E Preferred Stock) were actually owned by JAIC-Henson MedFocus Fund II, LLC.

5. Converted Series E Preferred Stock.

6. Not applicable.

7. The original Form 4 reflected 55,554 as the number of derivative securities disposed of by JAIC-Henson MedFocus Fund,LLC, but the accurate amount was 27,777, as 27,777 of the shares were owned by JAIC-Henson MedFocus Fund II, LLC.

Remarks:

	/s/Michael R. Henson by Robert A. Stern, Attorney-in-Fact.	10/03/2006
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.